Schedule 13G ownership disclosure
Castle Biosciences Inc
Security class unavailable · CUSIP: 14843C105
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,953,215
- Percent of class
- 11.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-20-002937
- Form type
- SC 13G
- Filer
- CASTLE BIOSCIENCES INC
- CIK
- CIK 1447362
- Filed
- Feb 12, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership